According to Debon Securities, obesity is the source of vari...

According to Debon Securities, obesity is the source of various chronic diseases, and the new round of diet pills will explode. It has high consumption and huge market space, and deserves great attention. GLP-1 drugs have good potential for development and may expand to other fields outside of the weight loss market. The market potential for GLP-1 diet pills is at the level of 100 billion US dollars, and it is predicted that the domestic market will also surge.